Outcome of biphenotypic acute leukemia

Haematologica

Volumn 84, Issue 8, 1999, Pages 699-706

  Killick, Sally ^a,b   Matutes, Estella ^a   Powles, Ray L ^a   Hamblin, Mike ^a   Swansbury, John ^a   Treleaven, Jennifer G ^a   Zomas, Athanasios ^a   Atra, Ayad ^a   Catovsky, Daniel ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biphenotypic leukemia; Philadelphia chromosome

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE LEUKEMIA; ADULT; ARTICLE; CHILD; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PROGNOSIS; RELAPSE; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TREATMENT OUTCOME; TUMOR STEM CELLS;

EID: 0032851206     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative group. Ann Intern Med 1985; 103:620-5.
2. Matutes E, Morilla R, Farahat N, et al. Definition of acute biphenotypic leukemia. Haematologica 1997; 82:64-6.
3. Gale RP. Hybrid acute leukaemia. Br J Haematol 1987; 65:261-4.
4. Mirro J, Zipf TF, Pui CH, et al. Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance. Blood 1985; 66:1115-23.
5. Kantarjian HM, Hirsch-Ginsberg C, Yee G, Huh Y, Freireich EJ, Stass S. Mixed-lineage leukemia revisited: Acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood 1990; 76:808-13.
6. Mirro J Jr, Kitchingman GR. The morphology, cyto-chemistry, molecular characteristics and clinical significance of acute mixed-lineage leukaemia. In: Scott CS, ed. Leukemia cytochemistry and diagnosis: principles and practice. Chichester: Ellis Horwood 1989. p. 155-8.
7. Greaves MF, Chan LC. Mixed lineage leukemia: the implications for hematopoietic differentiation. Blood 1986; 68:598-603.
8. Pui C-H, Dahl GV, Melvin S, et al. Acute leukemia with mixed lymphoid and myeloid phenotype. Br J Haematol 1984; 56:121.
9. Drexler HG, Thiel E, Ludwig WD. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 1991; 5:637-45.
10. Hanson CA, Abaza M, Sheldon S, Ross CW, Schnitzer B, Stoolman LM. Acute biphenotypic leukaemia: Immunophenotypic and cytogenetic analysis. Br J Haematol 1993; 84:49-60.
11. Wiersma SR, OrtegaJ, Sobel E, Weinberg KI. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 1991; 324:800-8.
12. Sobol RE, Mick R, Royston I, et al. Clinical importance of myeloid antigen expression in adult acute lymphoblasti leukemia. N Engl J Med 1987; 316:1111.
13. Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991; 77:2242-50.
14. Cross AH, Goorha RM, Nuss R, et al. Acute myeloid leukemia with T-lymphoid features: A distinct biologic and clinical entity. Blood 1988; 72:579.
15. Faharat N, van der Plas D, Praxedes M, Morilla R, Matutes E, Catovsky D. Demonstration of cytoplasmic and nuclear antigens by flow cytometry in acute leukaemia. J Clin Pathol 1994; 47:843-9.
16. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9:1783-6.
17. European Group for the Immunological Classification of Leukaemias. The value of c-kit in the diagnosis of biphenotypic acute leukemia. Leukaemia 1998; 12:2038.
18. Harrison CJ, Fitchett M, Potter AM, Swansbury CJ. A guide to cytogenetic studies in haematological disorders. Eugenics Society Occasional Papers, New Series No. 1, 1987.
19. Mehta J, Powles R, Singal S, et al. Idarubicin, highdose cytarabine, and etoposide for induction of remission in acute in leukemia. Semin Hematol. 1996; 33(4 Supp3):18-23.
20. Carbonell F, Swansbury J, Min T, et al. Cytogenetic findings in acute biphenotypic leukaemia. Leukemia 1996; 10:1283-7.
21. Moorman AV, Hagemeijer A, Charrin C, Rieder H, Secker-Walker LM. The translocations t(11;19) (q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. European 11q23 workshop participants. Leukemia 1998; 12:805-10.
22. Zomas AP, Swansbury GJ, Matutes E, et al. Bilineal acute leukemia of B and T lineage with a novel translocation t(9;17)(p11;q11). Leuk Lymphoma 1997; 25:179-85.
23. Reardon DA, Hanson CA, Roth MS, Castle VP. Lineage switch in Philadelphia chromosome positive acute lymphoblastic leukemia. Cancer 1994; 73:1526-32.
24. Pane F, Frigeri F, Camera A, et al. Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 1996; 10:741-5.
25. Shende AC, Zaslav AL, Redner A, et al. A de novo lineage switch from B-cell acute lymphoblastic leukemia to acute myeloid leukemia: a case report. Am J Hematol 1995; 50:75-7.
26. Childs CC, Hirsch-Ginsberg C, Culbert SJ, et al. Lineage heterogeneity in acute leukemias with the t(4;11) abnormality: implications for acute mixed lineage leukemias. Hematol Pathol 1988; 2:145-57.
27. Cuneo A, Ferrant A, Michaux JL, et al. Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica 1996; 81:423-7.
28. Sulak LE, ClareCN, Morale BA, Hansen KL, Montiel MM. Biphenotypic acute leukaemia in adults. Am J Clin Pathol 1990; 94:54-8.
29. Legrand O, Perrot JY, Simonin G, et al. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol 1998; 100:147-55.